|Articles|September 27, 2019

In the Lab eNewsletter

  • Pharmaceutical Technology\'s In the Lab eNewsletter-10-02-2019
  • Volume 14
  • Issue 10

Cytek Biosciences Achieves 40-Color Panel from a Single Sample with New Flow System

The cytometry system is available with up to five lasers to analyze up to 40 markers in one sample.

Cytek Biosciences, a flow cytometry instrumentation provider based in Fremont, CA, has developed and demonstrated a high-quality 40-color panel from a single sample using the Cytek Aurora advanced flow cytometry system.

The device uses various patent-pending technologies and allows users to combine their markers in one sample and achieve high resolution for each individual marker, according to a Sept. 25, 2019 press release. The cytometry system is available with up to five lasers to analyze up to 40 markers in one sample and provides users with flexible dye choices, the power to extract sample autofluorescence, intuitive workflows, and the ability to extract multiplexed high-quality data from a single test. 

“As the flow cytometry market continues to expand rapidly and reach an estimated $8.92 billion globally by 2026, we fully expect that the Aurora will become a large, powerful, and capable presence in the market,” said Dr. Wenbin Jiang, CEO of Cytek Biosciences, in the press release. “We are committed to addressing the lack of access to advanced scientific instrumentation and giving scientists the tools they need to take their fields to the next level. High-quality 40-color data makes in-depth insights and statistically powerful numbers from rare sample populations possible-and accelerates the pace of scientific discovery.”

Source: Cytek Biosciences

 

Related to this article

Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Complying with International Pharmacopoeias
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.